AbbVie Inc.
Explore AbbVie Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
AbbVie Inc.
Explore AbbVie Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2023 Revenue
$54.3B
▼ 6.4% vs FY2022 ($58.1B)
Source: Annual report / company filing
AbbVie Inc. reported $54.3B in revenue for fiscal year 2023. This represents a decline of 6.4% compared to the 2022 figure of $58.1B. In 2024, revenue increased to $56.3B.
Revenue fell as Humira biosimilars entered the US market in 2023.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $61.2B | — | +8.6% |
| FY2024 | $56.3B | $4.3B | +3.6% |
| FY2023 | $54.3B | — | -6.4% |
| FY2022 | $58.1B | — | +3.3% |
| FY2021 | $56.2B | — | +22.7% |
| FY2020 | $45.8B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.